ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Stratification of ovarian cancer patients from the prospect of drug target-related transcription factor protein activity: the prognostic and genomic landscape analyses

Su, Dongqing; Zhang, Haoxin; Xiong, Yuqiang; Wei, Haodong; Yu, Yao; Li, Honghao; Wang, Tao; Zuo, Yongchun*; Yang, Lei*哈尔滨医科大学
Briefings in Functional Genomics2023-7-17DOI: 10.1093/bfgp/elad008
1被引9阅读
引用收藏
分享

摘要

The expression and activity of transcription factors, which directly mediate gene transcription, are strictly regulated to control numerous normal cellular processes. In cancer, transcription factor activity is often dysregulated, resulting in abnormal expression of genes related to tumorigenesis and development. The carcinogenicity of transcription factors can be reduced through targeted therapy. However, most studies on the pathogenic and drug-resistant mechanisms of ovarian cancer have focused on the expression and signaling pathways of individual transcription factors. To improve the prognosis and treatment of patients with ovarian cancer, multiple transcription factors should be evaluated simultaneously to determine the effects of their protein activity on drug therapies. In this study, the transcription factor activity of ovarian cancer samples was inferred from virtual inference of protein activity by enriched regulon algorithm using mRNA expression data. Patients were clustered according to their transcription factor protein activities to investigate the association of transcription factor activities of different subtypes with prognosis and drug sensitivity for filtering subtype-specific drugs. Meanwhile, master regulator analysis was utilized to identify master regulators of differential protein activity between clustering subtypes, thereby identifying transcription factors associated with prognosis and assessing their potential as therapeutic targets. Master regulator risk scores were then constructed for guiding patients' clinical treatment, providing new insights into the treatment of ovarian cancer at the level of transcriptional regulation.

学科与关键词

关键词
ovarian cancertranscriptional regulationprotein activitymaster regulator analysis
相关
加载中…
  • Integrated analysis of ovarian cancer patients from prospective transcription factor activity reveals subtypes of prognostic significance
    Su, Dongqing; Xiong, Yuqiang; Wei, Haodong; Wang, Shiyuan; Ke, Jiawei; Liang, Pengfei; Zhang, Haoxin; Yu, Yao; Zuo, Yongchun*; Yang, Lei*Heliyon, 2023, 9(5): e16147.被引 2
  • Cancer-Associated Fibroblast-Related Genes Are Associated with Prognosis of Patients with Ovarian Cancer
    Bai, J.; Jiang, Z. J.; Zhao, X. P.; Wang, N. N.; Chen, A. J.*; Luo, Y. Z.*RUSSIAN JOURNAL OF GENETICS, 2023, 59(SUPPL 2): S208-S218.
  • Distinct expression and prognostic values of GATA transcription factor family in human ovarian cancer
    Zhou, Quan*; Yang, Huai-Jie; Zuo, Man-Zhen; Tao, Ya-LingJournal of Ovarian Research, 2022, 15(1): 49.被引 6
查看全部 →

发表信息

论文状态
公开发表
期刊
Briefings in Functional Genomics
发表日期
2023-07-17
卷期
第 22 卷, 第 4 期
页码
351-365
DOI
10.1093/bfgp/elad008
语言
ENGLISH
成果收录
SCIE

作者

  • S

    Su, Dongqing (第一作者)

    harbin med univ

  • Z

    Zhang, Haoxin

    harbin med univ

查看全部 9 位作者收起作者
  • X

    Xiong, Yuqiang

    harbin med univ

  • W

    Wei, Haodong

    harbin med univ

  • Y

    Yu, Yao

    harbin med univ

  • L

    Li, Honghao

    harbin med univ

  • W

    Wang, Tao

    harbin med univ

  • Z

    Zuo, Yongchun (通讯)

    inner mongolia univ

  • Y

    Yang, Lei (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417